{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:22:25Z","timestamp":1787908945165,"version":"build-2784847793"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Youth Medical Innovation Research Project of China","award":["No. P24021287620"],"award-info":[{"award-number":["No. P24021287620"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05627-6","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T08:24:05Z","timestamp":1783499045000},"page":"3789-3801","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting the GLIS1\/DNMT3B-mediated DNA Methylation of HOXA9 to Suppress Metastasis in Lung Adenocarcinoma"],"prefix":"10.1007","volume":"481","author":[{"given":"Ling","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"5627_CR1","doi-asserted-by":"publisher","unstructured":"Chen Y, Zhou Y, Ren R, Chen Y, Lei J, Li Y (2024) Harnessing lipid metabolism modulation for improved immunotherapy outcomes in lung adenocarcinoma. J Immunother Cancer 12. https:\/\/doi.org\/10.1136\/jitc-2024-008811","DOI":"10.1136\/jitc-2024-008811"},{"key":"5627_CR2","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1007\/s00262-020-02817-z","volume":"70","author":"M Yi","year":"2021","unstructured":"Yi M, Li A, Zhou L, Chu Q, Luo S, Wu K (2021) Immune signature-based risk stratification and prediction of immune checkpoint inhibitor\u2019s efficacy for lung adenocarcinoma. Cancer Immunol Immunother 70:1705\u20131719. https:\/\/doi.org\/10.1007\/s00262-020-02817-z","journal-title":"Cancer Immunol Immunother"},{"key":"5627_CR3","doi-asserted-by":"publisher","unstructured":"Behrend SJ, Giotopoulou GA, Spella M, Stathopoulos GT (2021) A role for club cells in smoking-associated lung adenocarcinoma. Eur Respir Rev 30. https:\/\/doi.org\/10.1183\/16000617.0122-2021","DOI":"10.1183\/16000617.0122-2021"},{"key":"5627_CR4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s13046-024-03184-8","volume":"43","author":"P Geng","year":"2024","unstructured":"Geng P, Ye F, Dou P, Hu C, He J, Zhao J, Li Q, Bao M, Li X, Liu X, Xu G (2024) HIF-1\u03b1-HPRT1 axis promotes tumorigenesis and gefitinib resistance by enhancing purine metabolism in EGFR-mutant lung adenocarcinoma. J Exp Clin Cancer Res 43:269. https:\/\/doi.org\/10.1186\/s13046-024-03184-8","journal-title":"J Exp Clin Cancer Res"},{"key":"5627_CR5","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1093\/annonc\/mdz288","volume":"30","author":"EJ Aguilar","year":"2019","unstructured":"Aguilar EJ, Ricciuti B, Gainor JF, Kehl KL, Kravets S, Dahlberg S, Nishino M, Sholl LM, Adeni A, Subegdjo S, Khosrowjerdi S, Peterson RM, Digumarthy S, Liu C, Sauter J, Rizvi H, Arbour KC, Carter BW, Heymach JV, Altan M, Hellmann MD, Awad MM (2019) Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression. Ann Oncol 30:1653\u20131659. https:\/\/doi.org\/10.1093\/annonc\/mdz288","journal-title":"Ann Oncol"},{"key":"5627_CR6","doi-asserted-by":"publisher","first-page":"30901","DOI":"10.1074\/jbc.M203563200","volume":"277","author":"YS Kim","year":"2002","unstructured":"Kim YS, Lewandoski M, Perantoni AO, Kurebayashi S, Nakanishi G, Jetten AM (2002) Identification of Glis1, a novel Gli-related, Kruppel-like zinc finger protein containing transactivation and repressor functions. J Biol Chem 277:30901\u201330913. https:\/\/doi.org\/10.1074\/jbc.M203563200","journal-title":"J Biol Chem"},{"key":"5627_CR7","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nature10106","volume":"474","author":"M Maekawa","year":"2011","unstructured":"Maekawa M, Yamaguchi K, Nakamura T, Shibukawa R, Kodanaka I, Ichisaka T, Kawamura Y, Mochizuki H, Goshima N, Yamanaka S (2011) Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1. Nature 474:225\u2013229. https:\/\/doi.org\/10.1038\/nature10106","journal-title":"Nature"},{"key":"5627_CR8","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.leukres.2015.06.005","volume":"39","author":"C Chen","year":"2015","unstructured":"Chen C, Bartenhagen C, Gombert M, Okpanyi V, Binder V, R\u00f6ttgers S, Bradtke J, Teigler-Schlegel A, Harbott J, Ginzel S, Thiele R, Husemann P, Krell PF, Borkhardt A, Dugas M, Hu J, Fischer U (2015) Next-generation-sequencing of recurrent childhood high hyperdiploid acute lymphoblastic leukemia reveals mutations typically associated with high risk patients. Leuk Res 39:990\u20131001. https:\/\/doi.org\/10.1016\/j.leukres.2015.06.005","journal-title":"Leuk Res"},{"key":"5627_CR9","doi-asserted-by":"publisher","unstructured":"Rong D, Wang Y, Liu L, Cao H, Huang T, Liu H, Hao X, Sun G, Sun G, Zheng Z, Kang J, Xia Y, Chen Z, Tang W, Wang X (2023) GLIS1 intervention enhances anti-PD1 therapy for hepatocellular carcinoma by targeting SGK1-STAT3-PD1 pathway. J Immunother Cancer 11. https:\/\/doi.org\/10.1136\/jitc-2022-005126","DOI":"10.1136\/jitc-2022-005126"},{"key":"5627_CR10","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1007\/s43032-023-01432-4","volume":"31","author":"J Huang","year":"2024","unstructured":"Huang J, Zhao Y (2024) Effect of GLIS1 on the Lymph Node Metastasis of Cervical Squamous Carcinoma Based on Transcriptome Analysis. Reprod Sci 31:1332\u20131344. https:\/\/doi.org\/10.1007\/s43032-023-01432-4","journal-title":"Reprod Sci"},{"key":"5627_CR11","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1387\/ijdb.180330rr","volume":"62","author":"R Krumlauf","year":"2018","unstructured":"Krumlauf R (2018) Hox genes, clusters and collinearity. Int J Dev Biol 62:659\u2013663. https:\/\/doi.org\/10.1387\/ijdb.180330rr","journal-title":"Int J Dev Biol"},{"key":"5627_CR12","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1515\/cclm.2011.108","volume":"49","author":"SH Hwang","year":"2011","unstructured":"Hwang SH, Kim KU, Kim JE, Kim HH, Lee MK, Lee CH, Lee SY, Oh T, An S (2011) Detection of HOXA9 gene methylation in tumor tissues and induced sputum samples from primary lung cancer patients. Clin Chem Lab Med 49:699\u2013704. https:\/\/doi.org\/10.1515\/cclm.2011.108","journal-title":"Clin Chem Lab Med"},{"key":"5627_CR13","doi-asserted-by":"publisher","first-page":"779","DOI":"10.14670\/hh-18-448","volume":"37","author":"ZL Li","year":"2022","unstructured":"Li ZL, Li D, Yin GQ (2022) MiR-19b-3p promotes tumor progression of non-small cell lung cancer via downregulating HOXA9 and predicts poor prognosis in patients. Histol Histopathol 37:779\u2013789. https:\/\/doi.org\/10.14670\/hh-18-448","journal-title":"Histol Histopathol"},{"key":"5627_CR14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s13402-019-00424-4","volume":"42","author":"SL Yu","year":"2019","unstructured":"Yu SL, Koo H, Lee HY, Yeom YI, Lee DC, Kang J (2019) Recombinant cell-permeable HOXA9 protein inhibits NSCLC cell migration and invasion. Cell Oncol (Dordr) 42:275\u2013285. https:\/\/doi.org\/10.1007\/s13402-019-00424-4","journal-title":"Cell Oncol (Dordr)"},{"key":"5627_CR15","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.1038\/ncomms4678","volume":"5","author":"K Takahashi","year":"2014","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Sasaki A, Yamamoto M, Nakamura M, Sutou K, Osafune K, Yamanaka S (2014) Induction of pluripotency in human somatic cells via a transient state resembling primitive streak-like mesendoderm. Nat Commun 5:3678. https:\/\/doi.org\/10.1038\/ncomms4678","journal-title":"Nat Commun"},{"key":"5627_CR16","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3389\/fonc.2019.01281","volume":"9","author":"N Shen","year":"2019","unstructured":"Shen N, Du J, Zhou H, Chen N, Pan Y, Hoheisel JD, Jiang Z, Xiao L, Tao Y, Mo X (2019) A Diagnostic Panel of DNA Methylation Biomarkers for Lung Adenocarcinoma. Front Oncol 9:1281. https:\/\/doi.org\/10.3389\/fonc.2019.01281","journal-title":"Front Oncol"},{"key":"5627_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.canlet.2020.04.007","volume":"482","author":"J Chen","year":"2020","unstructured":"Chen J, Liu A, Lin Z, Wang B, Chai X, Chen S, Lu W, Zheng M, Cao T, Zhong M, Li R, Wu M, Lu Z, Pang W, Huang W, Xiao L, Lin D, Wang Z, Lei F, Chen X, Long W, Zheng Y, Chen Q, Zeng J, Ren D, Li J, Zhang X, Huang Y (2020) Downregulation of the circadian rhythm regulator HLF promotes multiple-organ distant metastases in non-small cell lung cancer through PPAR\/NF-\u03bab signaling. Cancer Lett 482:56\u201371. https:\/\/doi.org\/10.1016\/j.canlet.2020.04.007","journal-title":"Cancer Lett"},{"key":"5627_CR18","doi-asserted-by":"publisher","unstructured":"Bartha \u00c1, Gy\u0151rffy B (2021) TNMplot.com: A Web Tool for the Comparison of Gene Expression in Normal, Tumor and Metastatic Tissues. Int J Mol Sci 22. https:\/\/doi.org\/10.3390\/ijms22052622","DOI":"10.3390\/ijms22052622"},{"key":"5627_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.canlet.2011.06.021","volume":"311","author":"JW Son","year":"2011","unstructured":"Son JW, Jeong KJ, Jean WS, Park SY, Jheon S, Cho HM, Park CG, Lee HY, Kang J (2011) Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients. Cancer Lett 311:29\u201337. https:\/\/doi.org\/10.1016\/j.canlet.2011.06.021","journal-title":"Cancer Lett"},{"issue":"Suppl 1","key":"5627_CR20","doi-asserted-by":"publisher","first-page":"E72","DOI":"10.1002\/mc.22180","volume":"54","author":"JA Hwang","year":"2015","unstructured":"Hwang JA, Lee BB, Kim Y, Hong SH, Kim YH, Han J, Shim YM, Yoon CY, Lee YS, Kim DH (2015) HOXA9 inhibits migration of lung cancer cells and its hypermethylation is associated with recurrence in non-small cell lung cancer. Mol Carcinog 54(Suppl 1):E72\u201380. https:\/\/doi.org\/10.1002\/mc.22180","journal-title":"Mol Carcinog"},{"key":"5627_CR21","doi-asserted-by":"publisher","unstructured":"Wen SWC, Andersen RF, Rasmussen K, Thomsen CB, Hansen TF, Nederby L, Hager H, Jakobsen A, Hilberg O (2021) Validating Methylated HOXA9 in Bronchial Lavage as a Diagnostic Tool in Patients Suspected of Lung Cancer. Cancers (Basel) 13. https:\/\/doi.org\/10.3390\/cancers13164223","DOI":"10.3390\/cancers13164223"},{"key":"5627_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","volume":"25","author":"DS Chandrashekar","year":"2022","unstructured":"Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, Netto GJ, Qin ZS, Kumar S, Manne U, Creighton CJ, Varambally S (2022) UALCAN: An update to the integrated cancer data analysis platform. Neoplasia 25:18\u201327. https:\/\/doi.org\/10.1016\/j.neo.2022.01.001","journal-title":"Neoplasia"},{"key":"5627_CR23","doi-asserted-by":"publisher","unstructured":"Yu SL, Koo H, Lee SI, Kang J, Han YH, Yeom YI, Lee DC (2020) A Synthetic CPP33-Conjugated HOXA9 Active Domain Peptide Inhibits Invasion Ability of Non-Small Lung Cancer Cells. Biomolecules 10. https:\/\/doi.org\/10.3390\/biom10111589","DOI":"10.3390\/biom10111589"},{"key":"5627_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41421-023-00528-0","volume":"9","author":"H Tian","year":"2023","unstructured":"Tian H, Liu C, Yu J, Han J, Du J, Liang S, Wang W, Liu Q, Lian R, Zhu T, Wu S, Tao T, Ye Y, Zhao J, Yang Y, Zhu X, Cai J, Wu J, Li M (2023) PHF14 enhances DNA methylation of SMAD7 gene to promote TGF-\u03b2-driven lung adenocarcinoma metastasis. Cell Discov 9:41. https:\/\/doi.org\/10.1038\/s41421-023-00528-0","journal-title":"Cell Discov"},{"key":"5627_CR25","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1016\/j.prp.2018.09.025","volume":"214","author":"X Song","year":"2018","unstructured":"Song X, Zhao C, Jiang L, Lin S, Bi J, Wei Q, Yu L, Zhao L, Wei M (2018) High PITX1 expression in lung adenocarcinoma patients is associated with DNA methylation and poor prognosis. Pathol Res Pract 214:2046\u20132053. https:\/\/doi.org\/10.1016\/j.prp.2018.09.025","journal-title":"Pathol Res Pract"},{"key":"5627_CR26","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1186\/s12885-024-12452-x","volume":"24","author":"J Zhao","year":"2024","unstructured":"Zhao J, Lu Y, Ren X, Bian T, Feng J, Sun H, Liu L, She B, Liu Y, Ke H (2024) Association of the SHOX2 and RASSF1A methylation levels with the pathological evolution of early-stage lung adenocarcinoma. BMC Cancer 24:687. https:\/\/doi.org\/10.1186\/s12885-024-12452-x","journal-title":"BMC Cancer"},{"key":"5627_CR27","doi-asserted-by":"crossref","unstructured":"Thasma LoganathBabu VK, Satishkartik S, Karthikeyan V, Chattopadhyay S, Ganesh PS, Rangasamy HN, Ramalingam K S and, Nagarajan AK (2025) RNA Binding Proteins are Pivotal Regulators of Cancer Radioresistance and Potential Targets for Preventing Tumor Recurrence. Current Radiopharmaceuticals","DOI":"10.2174\/0118744710366175250425101010"},{"key":"5627_CR28","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.2174\/1570180820666230914104206","volume":"21","author":"Y-Z Wei","year":"2024","unstructured":"Wei Y-Z, Yang M-Z, Yuan W (2024) Network Pharmacological Study of the active Ingredient of Panax Notoginseng Saponins for the treatment of lung cancer by Inhibiting AKR1C3. Lett Drug Des Discovery 21:1546\u20131554","journal-title":"Lett Drug Des Discovery"},{"key":"5627_CR29","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1242\/bio.20148193","volume":"3","author":"C Vadnais","year":"2014","unstructured":"Vadnais C, Shooshtarizadeh P, Rajadurai CV, Lesurf R, Hulea L, Davoudi S, Cadieux C, Hallett M, Park M, Nepveu A (2014) Autocrine Activation of the Wnt\/\u03b2-Catenin Pathway by CUX1 and GLIS1 in Breast Cancers. Biol Open 3:937\u2013946. https:\/\/doi.org\/10.1242\/bio.20148193","journal-title":"Biol Open"},{"key":"5627_CR30","doi-asserted-by":"publisher","unstructured":"Peng Q, Xie T, Wang Y, Ho VW, Teoh JY, Chiu PK, Ng CF (2023) GLIS1, Correlated with Immune Infiltrates, Is a Potential Prognostic Biomarker in Prostate Cancer. Int J Mol Sci 25. https:\/\/doi.org\/10.3390\/ijms25010489","DOI":"10.3390\/ijms25010489"},{"key":"5627_CR31","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.2174\/1570180820666230831095954","volume":"21","author":"R Ravichandran","year":"2024","unstructured":"Ravichandran R, Wilson DD, Viswanathan S, Siddikuzzaman, Bonati L, Rajendran S, Grace VB (2024) Synergistic Effects of Ethanol Extract of Allium sativum (Garlic) with DAPT and ATRA on Notch Signaling Targeted Molecular Action on Lung Cancer Cell line (A549). Lett Drug Des Discovery 21:2697\u20132710","journal-title":"Lett Drug Des Discovery"},{"key":"5627_CR32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12885-025-13633-y","volume":"25","author":"F Xie","year":"2025","unstructured":"Xie F, Zhang TJ, Zhang XL, Xu ZJ, Qiao L, Wang Y, Zhao YJ, Qian J, Zhou JD (2025) Identification of HOXA9 methylation as an epigenetic biomarker predicting prognosis and guiding treatment choice in acute myeloid leukemia. BMC Cancer 25:215. https:\/\/doi.org\/10.1186\/s12885-025-13633-y","journal-title":"BMC Cancer"},{"key":"5627_CR33","doi-asserted-by":"publisher","first-page":"e0137003","DOI":"10.1371\/journal.pone.0137003","volume":"10","author":"MO Kitchen","year":"2015","unstructured":"Kitchen MO, Bryan RT, Haworth KE, Emes RD, Luscombe C, Gommersall L, Cheng KK, Zeegers MP, James ND, Devall AJ, Fryer AA, Farrell WE (2015) Methylation of HOXA9 and ISL1 Predicts Patient Outcome in High-Grade Non-Invasive Bladder Cancer. PLoS ONE 10:e0137003. https:\/\/doi.org\/10.1371\/journal.pone.0137003","journal-title":"PLoS ONE"},{"key":"5627_CR34","doi-asserted-by":"publisher","first-page":"e22873","DOI":"10.1002\/jcla.22873","volume":"33","author":"C Zhou","year":"2019","unstructured":"Zhou C, Li J, Li Q, Liu H, Ye D, Wu Z, Shen Z, Deng H (2019) The clinical significance of HOXA9 promoter hypermethylation in head and neck squamous cell carcinoma. J Clin Lab Anal 33:e22873. https:\/\/doi.org\/10.1002\/jcla.22873","journal-title":"J Clin Lab Anal"},{"key":"5627_CR35","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.lungcan.2018.05.021","volume":"122","author":"D Lissa","year":"2018","unstructured":"Lissa D, Ishigame T, Noro R, Tucker MJ, Bliskovsky V, Shema S, Beck JA, Bowman ED, Harris CC, Robles AI (2018) HOXA9 methylation and blood vessel invasion in FFPE tissues for prognostic stratification of stage I lung adenocarcinoma patients. Lung Cancer 122:151\u2013159. https:\/\/doi.org\/10.1016\/j.lungcan.2018.05.021","journal-title":"Lung Cancer"},{"key":"5627_CR36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13148-025-01831-1","volume":"17","author":"A Vicente","year":"2025","unstructured":"Vicente A, de Souza Santos FA, Hirai WY, Lissa D, de Oliveira Cavagna R, da Silva ALV, Dos Reis MB, da Silva ECA, da Silva FAF, Mour\u00e3o JD, De Marchi P, de Carvalho AC, Leal LF, Reis RM (2025) HOXA9 methylation is not associated with survival in Brazilian patients with lung adenocarcinoma. Clin Epigenetics 17:25. https:\/\/doi.org\/10.1186\/s13148-025-01831-1","journal-title":"Clin Epigenetics"},{"key":"5627_CR37","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/febs.16268","volume":"290","author":"S Aryal","year":"2023","unstructured":"Aryal S, Zhang Y, Wren S, Li C, Lu R (2023) Molecular regulators of HOXA9 in acute myeloid leukemia. Febs j 290:321\u2013339. https:\/\/doi.org\/10.1111\/febs.16268","journal-title":"Febs j"},{"key":"5627_CR38","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2147\/ijgm.S350340","volume":"15","author":"Y Lao","year":"2022","unstructured":"Lao Y, Li T, Xie X, Chen K, Li M, Huang L (2022) MiR-195-3p is a Novel Prognostic Biomarker Associated with Immune Infiltrates of Lung Adenocarcinoma. Int J Gen Med 15:191\u2013203. https:\/\/doi.org\/10.2147\/ijgm.S350340","journal-title":"Int J Gen Med"},{"key":"5627_CR39","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/s42003-024-07339-3","volume":"7","author":"X Jia","year":"2024","unstructured":"Jia X, Tian J, Chen P, Dong J, Li L, Chen D, Zhang J, Liao D, He Z, Luo K (2024) Methylation-modulated PFTK1 regulates gefitinib resistance via Wnt\/\u03b2-catenin signaling in EGFR mutant non-small-cell lung cancer cells. Commun Biol 7:1649. https:\/\/doi.org\/10.1038\/s42003-024-07339-3","journal-title":"Commun Biol"},{"key":"5627_CR40","doi-asserted-by":"publisher","first-page":"2162170","DOI":"10.1080\/08941939.2022.2162170","volume":"36","author":"H Li","year":"2023","unstructured":"Li H, Yuan Y, Dong H, Wang T, Zhang D, Zhou L, Chen L, He X (2023) Foxo3a-Mediated DNMT3B Impedes Cervical Cancer Cell Proliferation and Migration Capacities through Suppressing PTEN Promoter Methylation. J Invest Surg 36:2162170. https:\/\/doi.org\/10.1080\/08941939.2022.2162170","journal-title":"J Invest Surg"},{"key":"5627_CR41","doi-asserted-by":"publisher","first-page":"4372","DOI":"10.7150\/ijbs.72397","volume":"18","author":"X Zhu","year":"2022","unstructured":"Zhu X, Xue C, Kang X, Jia X, Wang L, Younis MH, Liu D, Huo N, Han Y, Chen Z, Fu J, Zhou C, Yao X, Du Y, Cai W, Kang L, Lyu Z (2022) DNMT3B-mediated FAM111B methylation promotes papillary thyroid tumor glycolysis, growth and metastasis. Int J Biol Sci 18:4372\u20134387. https:\/\/doi.org\/10.7150\/ijbs.72397","journal-title":"Int J Biol Sci"},{"key":"5627_CR42","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41419-025-08042-9","volume":"16","author":"M Luan","year":"2025","unstructured":"Luan M, Zhu W, Feng Z, Jing F, Xing Y, Ma X, Wang Y, Ning B, Jia Y (2025) Helicobacter pylori-induced aberrant methylation of ID4 mediated by DNMT3B drives gastric cancer progression via DEC1-SHH signaling pathway. Cell Death Dis 16:713. https:\/\/doi.org\/10.1038\/s41419-025-08042-9","journal-title":"Cell Death Dis"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05627-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05627-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05627-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:15:00Z","timestamp":1787908500000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05627-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":42,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["5627"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05627-6","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"7 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of\n                      Helsinki\n                      . Approval was granted by the Ethics Committee of Central Hospital of Dalian University of Technology (Approval Number: 2025-083-01).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}}]}}